Sekiz bölmeli kolistinli agar besiyerinde acinetobacter baumannii türlerinde kolistin direncinin saptanması
Abstract
Keywords
Supporting Institution
Project Number
References
- 1. Munoz-Price LS, Weinstein RA. Acinetobacter infection. N Engl J Med. 2008; 358: 1271-81.
- 2. Savcı Ü, Özveren G, Bulut Y, et al. Klinik örneklerden izole edilen Acinetobacter baumannii suşlarının in-vitro duyarlılık durumları. Turk J Clin Lab. 2015; 6: 24-9
- 3. Owen RJ, Li J, Nation RL et al. In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates. J Antimicrob Chemother. 2007; 59: 473-7.
- 4. Li J, Rayner CR, Nation RL, et al. Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2006; 50: 2946-50.
- 5. Arroyo LA, García-Curiel A, Pachón-Ibañez ME, et al. Reliability of the E-test method for detection of colistin resistance in clinical isolates of Acinetobacter baumannii. J Clin Microbiol. 2005; 43: 903-5.
- 6. Lo-Ten-Foe JR, de Smet AM, Diederen BM, et al. Comparative evaluation of the VITEK 2, disk diffusion, etest, broth microdilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains. Antimicrob Agents Chemother. 2007; 51: 3726-30.
- 7. Tan TY, Ng LS, Poh K. Susceptibility testing of unconventional antibiotics against multiresistant Acinetobacter spp. by agar dilution and Vitek 2. Diagn Microbiol Infect Dis. 2007; 58: 357-61.
- 8. Tan TY, Ng SY. Comparison of Etest, Vitek and agar dilution for susceptibility testing of colistin. Clin Microbiol Infect. 2007; 13: 541-4.
Details
Primary Language
Turkish
Subjects
Health Care Administration
Journal Section
Research Article
Authors
Selim Görgün
*
Türkiye
Publication Date
June 30, 2021
Submission Date
October 8, 2020
Acceptance Date
February 8, 2021
Published in Issue
Year 2021 Volume: 12 Number: 2